Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

FDA perspective on regulatory issues in vaccine development

¹Division of Bacterial Products, Food and Drug Administration, Bethesda, Maryland 20892, USA.

Annals of the New York Academy of Sciences

|May 31, 1995

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.

Infection and immunity·1998

Same author

FDA research.

Nature medicine·1997

Same author

Lot-release criteria, postlicensure quality control, and the Haemophilus influenzae type b conjugate vaccines.

JAMA·1995

Same author

Relation between maternal age and serum concentration of IgG antibody to type III group B streptococci.

The Journal of infectious diseases·1994

Same author

Solid-phase antigen density and avidity of antibodies detected in anti-group B streptococcal type III IgG enzyme immunoassays.

Journal of immunological methods·1994

Same author

Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates.

The Journal of pediatrics·1993